Cost implications of clinical trial (CT) participation in metastatic non-small cell lung cancer (NSCLC).
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.7084
Abstract: 7084Background: To assess the value of CTs in advanced NSCLC from the payer perspective, we compared insurance-related total direct medical costs for NSCLC patients who enrolled in CTs vs. those wh... read more here.
Keywords: cost implications; clinical trial; participation metastatic; metastatic non ... See more keywords